Clinical Trial Update: A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

View source ↗

Summary

A clinical trial is evaluating Stapokibart Injection for Atopic Dermatitis and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Stapokibart Injection (Stapokibart)

Snippet

Sponsor: Chengdu Kangnuoxing Biopharma,Inc. | Conditions: Atopic Dermatitis (AD) | Status: NOT_YET_RECRUITING